CT检查在原发性肝癌患者经肝动脉化疗栓塞术后疗效评估中的应用价值分析

doi:10.3969/j.issn.1672-5069.2018.02.024

摘要/Abstract

摘要： 目的探讨电子计算机断层扫描（CT）在原发性癌（PLC）患者经肝动脉化疗栓塞术（TACE）治疗后疗效评估中的应用价值。方法 2015年10月~2016年12月行TACE治疗的92例PLC患者,在TACE术前后进行CT平扫及增强扫描,比较肝内病灶密度、强化方式、边界及大小变化,探讨CT检查对术后疗效评估的价值。结果在73例肿块型PLC患者,Ⅰ型碘油沉积22例（30.1%）,Ⅱ型40例（54.7%）,Ⅲ型8例（10.9%）,Ⅳ型3例（4.1%）,在19例结节型PLC患者,Ⅰ型碘油沉积14例（73.6%）,Ⅱ型4例（21.0%）,Ⅲ型1例（5.2%）;肿块型PLC患者TACE治疗后总有效率为95.5%（69/73）,结节型为94.7%（18/19）,两组差异无统计学意义（P>0.05）。结论 CT检查能有效评估PLC患者TACE治疗后的临床疗效,为临床制定进一步的治疗方案提供确切的影像学资料支持。

关键词: 原发性肝癌, 电子计算机断层扫描, 经肝动脉化疗栓塞术, 疗效评估

Abstract: Objective To investigate the computed tomography （CT） scan in evaluating the therapeutic effect of transcatheter arterial chemoembolization（TACE） in patients with primary liver cancer（PLC）. Methods The clinical data of 92 patients with PLC treated by TACE in our hospital between October 2015 and December 2016 were retrospectively collected. The CT scan and enhanced scan were performed before and after TACE. The density,enhancement patterns,border and size of the intrahepatic lesions before and after TACE were compared. Results There were 22 cases （30.1%） of type I,40 cases （54.7%） of type II,8 cases （10.9%） of type III and 3 cases（4.1%） of type IV lipiodol deposition in 73 patients with intrahepatic huge mass,and there were 14 cases（73.6%） of type I,4 cases（21%） of type II and 1 cases （5.2%） of type III lipiodol deposition in 19 patients with intrahepatic nodular lesions. The total effective rates in the two groups after TACE treatment were 95.5% （69/73） and 94.7% （18/19,P>0.05）. Conclusion CT examination is effective in evaluating the clinical efficacy of TACE treatment in patients with PLC, which provides accurate imaging information for further clinical strategy.

Key words: Hepatoma, Computed tomography, Transcatheter arterial chemoembolization, Evaluation

石朋, 王坤, 沈俊春, 卢文波. CT检查在原发性肝癌患者经肝动脉化疗栓塞术后疗效评估中的应用价值分析[J]. 实用肝脏病杂志, 2018, 21(2): 253-256.

Shi Peng, Wang Kun, Shen Junchun, et al. Application of computed tomography scan in evaluating therapeutic effect of transcatheter arterial chemoembolization in patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 253-256.

参考文献

[1] Minami Y,Kudo M.Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma:ultrasonography,CT and MR imaging. Oncology,2013,84(Suppl 1):58-63.
[2] Miyayama S,Matsui O,Zen Y,et al.Portal blood supply to locally progressed hepatocellular carcinoma after transcatheter arterial chemoembolization:observation on CT during arterial portography. Hepatol Res,2011,41(9):853-866.
[3] Lee S,Kim K A,Park M S,et al.MRI findings and prediction of time to progression of patients with hepatocellular carcinoma treated with drug-eluting bead transcatheter arterial chemoembolization. J Kor Med Sci,2015,30(7):965-973.
[4] 宋海燕,刘波,张骏飞,等. CIK细胞输注联合TACE治疗延缓原发性肝癌患者门静脉癌栓的形成. 实用肝脏病杂志,2016,19(3):318-321.
[5] 杜文杰,刘祖炳,刘华生.原发性肝癌介入治疗中经导管肝动脉栓塞与肝动脉灌注化疗栓塞的远期疗效比较.中华肿瘤治杂志,2016,10(s2):169-191.
[6] Minami Y,Takita M,Tsurusaki M,et al.Semiquantitative prediction of early response of conventional transcatheter arterial chemoembolization for hepatocellular carcinoma using postprocedural plain cone-beam computed tomography. Hepatol Res,2016,23(1):236-237.
[7] Yoshimatsu R,Yamagami T,Ishikawa M,et al.Change in imaging findings on angiography-assisted CT during balloon-occluded transcatheter arterial chemoembolization for hepatoce-llular carcinoma. Cardiovasc Intervent Radiol,2016,39(6):865-874.
[8] 张艳梅,崔红利,颜綦先,等. CIK细胞疗法联合TACE治疗原发性肝癌患者临床疗效观察.实用肝脏病杂志,2015,12(6):647-650.
[9] Pung L,Ahmad M,Mueller K,et al.The role of cone-beam CT in transcatheter arterial chemoembolization for hepatocellular carcinoma:a systematic review and meta-analysis. J Vasc Interv Radiol,2017,28(3):334-341.
[10] Chen HB,Huang Y,Dai DL,et al.Therapeutic effect of transcatheter arterial chemoembolization and percutaneous injection of acetic acids on primary liver cancer. Hepatobiliary Pancreat Dis Int,2004,3(1):55-57.
[11] Xuan ZD,Zhou L,Wang Y,et al.Prognostic value of the combination of serum levels of vascular endothelial growth factor,C-reactive protein and contrast-enhanced ultrasound in patients with primary liver cancer who underwent transcatheter arterial chemoembolization. Expert Rev Anticancer Ther,2017,17(12):1169-1178.
[12] 陈志刚,黄超源,连芳,等. 早期肝细胞癌射频消融联合肝动脉化疗栓塞与手术切除疗效Meta分析. 中华肿瘤防治杂志,2015,22(1):59-65.
[13] 马丽丽,韩忠诚,柳江. 肝动脉化疗栓塞术联合索拉菲尼治疗肝细胞肝癌的临床疗效与安全性评价. 中国临床药理学杂志,2015,30(15):1497-1499.
[14] Kamran AU,Liu Y,Li FE,et al.Transcatheter arterial chemoembolization with gelatin sponge microparticles treated for BCLC stage B hepatocellular carcinoma:a single center retrospective study. Medicine,2015,94(52):e2154.
[15] 白琛,唐芳,骆伟,等. 肝动脉化疗栓塞联合CT引导射频消融序贯治疗肝细胞癌的近远期疗效.中国医药,2015,10(8):1156-1160.
[16] Yang H,Zhou S,Shen R,et al.Evaluation on efficacy and safety of arsenic trioxide plus transcatheter arterial chemoembolization versus transcatheter arterial chemoembolization alone for unresectable primary liver cancer. Asian Pac J Cancer Prev,2017,18(10):2695-2701.
[17] Li W,Wang Y,Gao W,et al.Combination of transcatheter arterial chemoembolization and CT-guided percutaneous segment ablation for hepatocellular carcinoma therapy:A retrospective study. Medicine (Baltimore),2016,95(47):e5422.
[18] Hiraoka A,Ishimaru Y,Kawasaki H,et al.T umor markers AFP,AFP-L3,and DCP in hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Oncology,2015, 89(3):12-15.
[19] 王文娟,白梅,蔡江涛,等. 肝脏超声造影诊断肝癌术后肝内肿瘤复发的价值探讨. 实用肝脏病杂志,2016,19(2):214-216.
[20] Zhang D,Xu A.Application of dual-source CT perfusion imaging and MRI for the diagnosis of primary liver cancer. Oncol Lett,2017,14(5):5753-5758.
[21] Seki T,Tamai T,Nakagawa T,et al.Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer,2015,89(6):1245-1251.
[22] 廖毓菁,黄静,胡晓云,等. 原发性肝癌患者临床诊疗现状分析及多学科协作诊疗的初步探讨. 实用肝脏病杂,2015,19(5):512-516.
[23] Minami Y,Yagyu Y,Murakami T,et al.Tracking navigation imaging of transcatheter arterial chemoembolization for hepatocellular carcinoma using three-dimensional cone-beam CT angiography. Liver Cancer,2014,3(1):53-61.
[24] Li S,Zhang L,Huang ZM,et al.Transcatheter arterial chemoembolization combined with CT-guided percutaneous thermal ablation versus hepatectomy in the treatment of hepatocellular carcinoma. Clin J Cancer,2015,34(6):254-263.
[25] 王猛,蔡华崧,高进云,等. 非刚性三维校正肝脏MR动态减影技术应用于肝细胞癌经导管动脉内化疗栓塞术后疗效评估的研究. 中华普通外科学文献电子版,2015,9(5):44-48.
[26] 金国贤,刘春宽,蒋雁,等. 经导管肝动脉内化疗栓塞术联合DC-CIK治疗对中晚期肝细胞癌免疫功能的影响及其临床疗效. 解放军医药杂志,2016,28(4):43-47.
[27] 须新涛,耿辉,黄建峰,等. 肝动脉化疗栓塞联合索拉菲尼治疗中晚期肝细胞癌的临床疗效评估. 现代生物医学进展,2016,16(15):2935-2937.
[28] 蒋水明,张其顺,卢海明,等. 肝切除联合射频消融及经肝动脉化疗栓塞术治疗多发性肝细胞肝癌. 中华普通外科杂志,2015,30(11):855-857.
[29] 邢古生,王爽,李忱瑞,等. 宝石能谱CT 成像碘含量测定法在肝细胞癌患者经动脉化疗栓塞术后随访中的应用. 中华肿瘤杂志,2015,36(3):208-212.
[30] 许俊锋,王剑华,董文英. 磁共振扩散加权成像在肝细胞癌肝动脉化疗栓塞术后疗效监测中的价值. 中国现代医学杂志,2015,25(31):96-98.